| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhich black-seed preparation and stone question are selected?Required |
The original effect description concerns increased complete clearance or expulsion of adult kidney stones; the selected endpoint is complete disappearance on ultrasound. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Adult kidney stones, ground-seed capsules, placebo, 10 weeks and complete ultrasound disappearance |
Material needed: Original trial question, endpoint definitions and eligibility criteria This records needed materials; no new research was executed. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionWhat seed formulation is the 500 mg capsule?Required |
The retained intervention description specifies Nigella sativa L. seeds and ground-seed 500 mg capsules. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Nigella sativa L. seeds, ground-seed 500 mg capsules, composition and quality |
Material needed: Product composition, raw-material/batch analyses, manufacture and quality material This records needed materials; no new research was executed. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionAre seeds, fixed oil, extracts and thymoquinone the same intervention?Required |
The original product description states that seed powder, fixed oil, aqueous extracts, ethanolic topical preparations, purified thymoquinone and combinations are not interchangeable. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Distinguish the original formulation from fixed oil, aqueous extracts, topical preparations, purified constituents and combinations |
Material needed: Formulation-specific composition and original trials directly addressing the same question This records needed materials; no new research was executed. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionWhat was the actual exposure to 500 mg, 2 times daily?Required |
The original dose is 500 mg, 2 times daily. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Dose per 1 administration, frequency, use records, constituent quantification and adherence |
Material needed: Administration procedures, product content and use diaries This records needed materials; no new research was executed. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionWhat was the actual schedule for 10 weeks of treatment and ultrasound follow-up?Required |
The retained duration is 10 weeks of treatment and ultrasound follow-up. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Treatment start/end, ultrasound visits, discontinuation and subsequent follow-up |
Material needed: Treatment/ultrasound visit schedules and discontinuation/follow-up material This records needed materials; no new research was executed. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionWhich adults and which kidney stones were studied?Required |
The retained population is limited to adults with kidney stones. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Adults, kidney-stone diagnosis, inclusion/exclusion and baseline conditions |
Material needed: Participant eligibility/baseline tables and diagnostic criteria This records needed materials; no new research was executed. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionWhat were stone size, location, composition and number?Required |
The original explanation describes limited reporting of stone location and spontaneous-passage influences. It cautions against extending results to every size, composition and location. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Baseline size/location/composition by group, single/multiple stones and likelihood of passage |
Material needed: Baseline stone characteristics, imaging tables and composition material This records needed materials; no new research was executed. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionWhat was actually compared with matched placebo?Required |
The retained comparison is matched placebo and the design description is a randomized, triple-blind, placebo trial. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Placebo composition/appearance, common management and masking conditions |
Material needed: Placebo composition and common treatment/management tables This records needed materials; no new research was executed. |
| 9 |
Unverified |
Full text not readStored summary read |
N09 · Evidence conditionHow did hydration, diet, drugs and procedures differ?Required |
The original explanation mentions limited reporting of hydration, stone location and spontaneous-passage influences. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Hydration/diet, stone medication/standard management, additional procedures and group differences |
Material needed: Hydration/diet/concomitant-treatment, procedure and change records This records needed materials; no new research was executed. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionHow do complete ultrasound disappearance and actual expulsion differ?Required |
The retained principal endpoint is complete disappearance of stones on ultrasound. The original effect description uses both disappearance and expulsion. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Ultrasound disappearance, confirmation of actual expulsion, operational definitions and correspondence |
Material needed: Definitions of complete disappearance/expulsion, confirmation of expulsion and original imaging-assessment material This records needed materials; no new research was executed. |
| 11 |
Unverified |
Full text not readStored summary read |
N11 · Evidence conditionWhat does dissolution in the study title establish?Supplementary; required if extending to dissolution mechanisms |
The article title includes kidney stone dissolution, but the retained verdict selects complete ultrasound disappearance. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Distinguish imaging disappearance, expulsion and chemical dissolution/mechanisms |
Material needed: Original trial endpoints/measurements and stone-composition/expulsion material This records needed materials; no new research was executed. |
| 12 |
Unverified |
Full text not readStored summary read |
N12 · Evidence conditionAre complete-disappearance events and size reduction the same outcome?Required |
The retained endpoint is complete ultrasound disappearance; size reduction is separate, and the original explanation also states that these outcomes should not be mixed. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Size units, measurement/timing, between-group change and separation from complete disappearance |
Material needed: Separate size-reduction result tables, imaging measurements and denominators This records needed materials; no new research was executed. |
| 13 |
Unverified |
Full text not readStored summary read |
N13 · Evidence conditionWhich assessment procedures determined ultrasound disappearance?Required |
The original text describes ultrasound assessment of stone status and limited reporting of imaging-assessment procedures. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Imaging equipment, sensitivity, assessors/masking, agreement and confirmation of disappearance |
Material needed: Ultrasound SOPs, masking/assessment procedures and original images This records needed materials; no new research was executed. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Evidence conditionHow do 60 randomized participants differ from analysis groups?Required |
The retained participant record states 60 randomized; percentage-based analysis approximately 27 versus 26. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Randomization and arm-specific allocation, analysis, completion and endpoint denominators |
Material needed: CONSORT flow and arm-specific allocation/analysis tables This records needed materials; no new research was executed. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionHow were the approximately 27 and 26 analysis participants recorded?Required |
The original explanation states that 44.4% and 15.3% came from small analysis groups of approximately 27 and 26. The original participant record also states percentage-based analysis approximately 27 versus 26. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Reported percentages, historical reconstruction, original denominators, rounding and units |
Material needed: Original event/denominator tables, flow and original rounding/calculation records This records needed materials; no new research was executed. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionAre 12/27 versus 4/26 original counts or reconstructions?Required |
The result labels 12/27 versus 4/26 as reconstructed, while the reader answer presents approximately 12/27 versus 4/26. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Original event counts, reconstructed counts, approximation labels, denominators and group correspondence |
Material needed: Original frequency tables and historical reconstruction records This records needed materials; no new research was executed. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionWhich endpoint do the reported 44.4% versus 15.3% describe?Required |
The original result and reader answer report complete disappearance of 44.4% versus 15.3%. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Complete-disappearance percentages, group correspondence, timing, units and denominators |
Material needed: Complete-disappearance result tables, group denominators and definitions This records needed materials; no new research was executed. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionWhat are the sources of RD 29.1 percentage points, RR 2.89 and the CI?Required |
The original result reports RD 29.1 percentage points and RR 2.89 (95% CI 1.07 to 7.82) with reconstructed counts. Its note explicitly identifies a Codex reconstruction rather than adjusted paper estimates. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Original estimates versus reconstructed risk differences/RRs/CIs, effect of interest and adjustment |
Material needed: Original effect tables and historical calculation-event records This records needed materials; no new research was executed. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionWhat uncertainty remains with few events and a wide interval?Required |
The original reader answer describes small absolute event counts and the need to reproduce imaging/spontaneous-passage conditions. The historical RR CI is 1.07 to 7.82. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Intervals for the effect of interest, direct events/denominators and clinical importance |
Material needed: Original counts/effects and sample-size/clinical-importance plans This records needed materials; no new research was executed. |
| 20 |
Unverified |
Full text not readStored summary read |
N20 · Evidence conditionWhat was the 1st endpoint in the prospective trial plan?Required |
The retained intervention record labels complete ultrasound disappearance as the primary endpoint; the registration identifier is unconfirmed. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Registration, protocol, SAP and original endpoint/timing/analysis hierarchy |
Material needed: Registration/protocol/SAP and change histories This records needed materials; no new research was executed. |
| 21 |
Unverified |
Full text not readStored summary read |
N21 · Evidence conditionHow were sequence generation, concealment and baseline balance handled?Required |
The original design is described as a randomized, triple-blind, placebo trial, with 60 randomized participants. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Random sequence/concealment, allocation and baseline stone/participant balance |
Material needed: Allocation procedures and baseline tables This records needed materials; no new research was executed. |
| 22 |
Unverified |
Full text not readStored summary read |
N22 · Evidence conditionWhich roles remained masked?Required |
The original design description states triple blinding. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Participants, personnel and assessors, product distinguishability and maintenance of masking |
Material needed: Placebo/preparations, role-specific masking and assessment procedures This records needed materials; no new research was executed. |
| 23 |
Unverified |
Full text not readStored summary read |
N23 · Evidence conditionHow were actual use, discontinuation and additional treatment handled?Required |
The original record specifies 500 mg, 2 times daily, 10 weeks of treatment and comparison with placebo. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Use diaries, nonadherence/discontinuation, additional treatment and the effect targeted in analysis |
Material needed: Use diaries, deviation/procedure records and analysis plans This records needed materials; no new research was executed. |
| 24 |
Unverified |
Full text not readStored summary read |
N24 · Evidence conditionWho among the 60 randomized participants was omitted from analysis?Required |
The original participant record combines 60 randomized with percentage-based analysis of approximately 27/26. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Group-specific flow, withdrawal/missingness, ITT/PP, original denominators and handling |
Material needed: Group-specific flow, analysis definitions and missing-data handling This records needed materials; no new research was executed. |
| 25 |
Unverified |
Full text not readStored summary read |
N25 · Evidence conditionWhen and for whom was complete disappearance assessed?Required |
The recorded duration is 10 weeks of treatment and ultrasound follow-up. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Clearance-assessment timing, interim/end visits, cumulative/single-visit events and denominators |
Material needed: Visit-specific clearance tables, event timing and follow-up/denominators This records needed materials; no new research was executed. |
| 26 |
Unverified |
Full text not readStored summary read |
N26 · Evidence conditionHow were event units for people and stones defined?Required |
The original reader answer explains 12/27 and 4/26 in the context of participant denominators. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
People/stones, multiple stones, complete-clearance criteria and group denominators |
Material needed: Person/stone definitions and multiple-stone/denominator tables This records needed materials; no new research was executed. |
| 27 |
Unverified |
Full text not readStored summary read |
N27 · Evidence conditionHow were spontaneous passage and intervention effects distinguished?Required |
The original explanation describes limited reporting of hydration, stone location and spontaneous-passage influences. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Hydration/location/size, spontaneous passage, comparison conditions and assessment/timing |
Material needed: Baseline stones, hydration/common management and expulsion/adjustment material This records needed materials; no new research was executed. |
| 28 |
Unverified |
Full text not readStored summary read |
N28 · Evidence conditionHow were analyses of clearance, size and expulsion specified in advance?Required |
The original endpoint description separates complete disappearance from size reduction; the registration identifier is unconfirmed. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Planned endpoints, analyses/timing, multiple comparisons and reporting changes |
Material needed: Plans/registration and result tables for all analyses/times This records needed materials; no new research was executed. |
| 29 |
Unverified |
Full text not readStored summary read |
N29 · Evidence conditionDoes a clearance signal establish replacement of standard care or effects on symptoms/kidney function?Supplementary; required if extending to treatment replacement or additional effects |
The original advertising-boundary text states that replacement of surgery/standard care cannot be claimed for stones of every size, composition and location. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Standard treatment/procedures, pain/infection/obstruction, kidney function and patient-important outcomes |
Material needed: Patient-important outcomes and standard-care coadministration/procedure material This records needed materials; no new research was executed. |
| 30 |
Partly verified |
Full text not readStored summary read |
N30 · Evidence conditionWhich original report do the current summary and citation identify?Required |
The original citation is Ardakani Movaghati MR et al., Phytother Res.2019, PMID30873671, DOI10.1002/ptr.6331. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Evidence/citation, PMID/DOI and study-report families |
Material needed: Article/registration and lists of reports from the same trial This records needed materials; no new research was executed. |
| 31 |
Partly verified |
Full text not readStored summary read |
N31 · Evidence conditionHas the small-sample signal been repeated in other independent material?Required |
The original rationale lists independent research as a strength while noting a single small sample, denominator reconstruction and imaging limitations. The original R1/I2 axes are retained. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Teams/trial families, the same formulation/conditions and independent replication |
Material needed: Original trials addressing the same formulation/question and imaging/expulsion conditions This records needed materials; no new research was executed. |
| 32 |
Unverified |
Full text not readStored summary read |
N32 · Evidence conditionWhat was the actual role of Mashhad University support?Required |
The original funding record states support from Mashhad University. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Funding/product support, affiliations, COI and support roles |
Material needed: Original funding/COI, author-affiliation and product-support disclosures This records needed materials; no new research was executed. |
| 33 |
Partly verified |
Full text not readStored summary read |
N33 · Evidence conditionWere the PubMed link, original article and registration read?Required |
The clinical material read was the entire stored JSON summary. The PubMed URL is recorded as in the original citation. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Stored JSON, external abstracts/full text, registration/plans and acquisition/reading |
Material needed: Original text, registration/plans and supplementary material corresponding to the citation This records needed materials; no new research was executed. |
| 34 |
Partly verified |
Full text not readStored summary read |
N34 · Evidence conditionWhat dates are 2026-09-08 and the correction date?Required |
The original evidence date is 2026-09-08, the correction date is 2026-09-14 and the bibliography is from 2019. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Roles of the original evidence date, correction/bibliography and current preparation date |
Material needed: Original search, receipt, publication and correction records This records needed materials; no new research was executed. |
| 35 |
Partly verified |
Full text not readStored summary read |
N35 · Evidence conditionAre generic English wording and the 1-field correction retained?Required |
The English reader answer gives approximately 12/27 and 4/26 and historical RR/CI. Generic explanations remain for English funding, endpoint and result fields, while the English participant explanation describes preservation without actual denominators. The correction records replacement of 1 field. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Korean/English numbers, generic explanations and before/after correction events |
Material needed: Complete before/after correction originals and English result/denominator correspondence This records needed materials; no new research was executed. |
| 36 |
Partly verified |
Full text not readStored summary read |
N36 · Evidence conditionWhat roles do C56 and historical Codex reconstruction/cross-checks have here?Required |
The original C56, Caution, B/H/R1/I2/E+/B2/C0 axes and historical independent Codex cross-check/reconstruction wording are preserved in the original copy. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Separate grade, score, caution label, axes, verdict decisions, historical calculation and current preparation |
Material needed: Original verdict/reconstruction events and separately authorized subsequent corrections This records needed materials; no new research was executed. |
| 37 |
Partly verified |
Full text not readStored summary read |
N37 · Evidence conditionFrom which denominators were actual adverse events for this formulation collected?Required |
The original safety text states that small trials do not exclude rare adverse events or long-term safety concerns. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Event definitions/collection, group event/person counts, harm denominators and discontinuation/missingness |
Material needed: Original adverse-event/discontinuation tables and group-specific collection/denominators This records needed materials; no new research was executed. |
| 38 |
Unverified |
Full text not readStored summary read |
N38 · Evidence conditionWhat are the onset/recovery and concomitant-condition/treatment limits for harms?Required |
The original text records the oral 10-week exposure and general cautionary wording. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Event timing, discontinuation/re-exposure, baseline conditions/concomitant drugs and alternative causes |
Material needed: Individual event timing, concomitant treatment/baseline conditions and causal material This records needed materials; no new research was executed. |
| 39 |
Unverified |
Full text not readStored summary read |
N39 · Evidence conditionAre drugs mentioned in cautions actual interaction events?Supplementary; required for concomitant-use harms |
The retained safety explanation preserves cautionary wording to consult a clinician while taking relevant drugs. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Glucose-lowering, blood-pressure, anticoagulant, antiseizure and immunomodulatory drugs, exposures/events and alternatives |
Material needed: Drug-specific exposure/formulation and original interaction material This records needed materials; no new research was executed. |
| 40 |
Partly verified |
Full text not readStored summary read |
N40 · Evidence conditionWhat remains unknown about rare/long-term safety and vulnerable groups?Supplementary; required for long-term or vulnerable-population safety |
The original text describes constituent differences between products/extraction methods, cautions for vulnerable groups/perioperative use and the inability of small trials to exclude rare/long-term harms. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Duration/formulation, pregnancy/breastfeeding, children, liver/kidney disease, perioperative use and rare harms |
Material needed: Long-term/rare, formulation-specific and population-specific harm material This records needed materials; no new research was executed. |
| 41 |
Unverified |
Full text not readStored summary read |
N41 · Evidence conditionIs the same formulation/event recorded in independent material?Supplementary; required for repeated-harm claims |
The retained text preserves general cautionary wording and does not present an actual unique-case list. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Unique harm cases, report families and matching formulation/exposure/event |
Material needed: Unique cases/report families and actual formulation/exposure material This records needed materials; no new research was executed. |
| 42 |
Partly verified |
Full text not readStored summary read |
N42 · Evidence conditionHow are unread material and subsequent changes connected?Required |
The stored JSON summary is used for preparation and only the original PubMed link is connected. External material was unread, with no access attempt. |
Information retained in stored summaries is linked to gaps in detailed material. External verification and content review remain incomplete; fulfilled conditions, effects, safety, prespecification and independence are not certified. |
Stored summary, external articles/registration/denominators/imaging, complete pre-change originals and condition/evidence events |
Material needed: User-provided or separately authorized original material and corrections This records needed materials; no new research was executed. |